We are live on ! Find out more
HQL

abrdn Life Sciences Investors

57 hedge funds and large institutions have $64.6M invested in abrdn Life Sciences Investors in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 12

7% more capital invested

Capital invested by funds: $60.2M → $64.6M (+$4.32M)

0.19% less ownership

Funds ownership: 14.56%14.37% (-0.19%)

3% less funds holding

Funds holding: 5957 (-2)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

Holders
57
Holders Change
-2
Holders Change %
-3.39%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
9
Increased
26
Reduced
12
Closed
11
Calls
Puts
Net Calls
Net Calls Change

HQL Hedge Fund Activity: Q3 2018 in Review

57 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2018, worth a combined $64.6M — up 7.2% from $60.2M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of HQL and 9 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 26 added.

The largest buyer was Wells Fargo, adding an estimated $583K. The largest seller was Morgan Stanley, cutting an estimated $1.18M.

  • 57 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2018, down from 59 in Q2 2018.
  • Funds reported $64.6M of abrdn Life Sciences Investors stock for Q3 2018, up 7.2% quarter-over-quarter.
  • 9 funds opened new abrdn Life Sciences Investors positions in Q3 2018 and 11 closed out, a net change of -2 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2018 was Wells Fargo, an estimated $583K added.
  • The largest abrdn Life Sciences Investors seller in Q3 2018 was Morgan Stanley, an estimated $1.18M sold.

Based on aggregated 13F filings for Q3 2018.